Rathbun, R Chris <br/><br/>
Dolutegravir, a second-generation integrase inhibitor for the treatment of HIV-1 infection.  [electronic resource] 

 -  The Annals of pharmacotherapy  Mar 2014 
 - 395-403 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1542-6270 
<br/><br/><label>Standard No.: </label>10.1177/1060028013513558  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkynes<br/>Benzoxazines--therapeutic use<br/>Clinical Trials as Topic<br/>Cyclopropanes<br/>Drug Combinations<br/>Drug Interactions<br/>HIV Infections--drug therapy<br/>HIV Integrase Inhibitors--pharmacology<br/>HIV Protease Inhibitors--therapeutic use<br/>Half-Life<br/>Heterocyclic Compounds, 3-Ring--pharmacology<br/>Humans<br/>Oxazines<br/>Piperazines<br/>Pyridones<br/>Pyrrolidinones--therapeutic use<br/>Raltegravir Potassium<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Ritonavir--therapeutic use